RESPONSE TO NEOADJUVANT THERAPY IN PATIENTS WITH EARLY-ONSET RECTAL CANCER.

被引:0
|
作者
Foppa, C.
Maroli, A.
Carvello, M.
Cianchi, F.
Montorsi, M.
Spinelli, A.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P200
引用
收藏
页码:E198 / E198
页数:1
相关论文
共 50 条
  • [21] Gene expression profiles in Hispanic patients with early-onset gastric cancer.
    Ju, Michelle R.
    Hong, Changjin
    Karalis, John D.
    Hammer, Suntrea
    Porembka, Matthew R.
    Hwang, Tae Hyun
    Wang, Sam C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 464 - 464
  • [22] Development and application of DNA Repair Dysregulation Score in predicting response to neoadjuvant therapy in patients with rectal cancer.
    Jimenez, Leandro
    Koyama, Fernanda
    DeVecchio, Jennifer
    Kalady, Mathew
    Habr-Gama, Angelita
    Perez, Rodrigo
    Camargo, Anamaria
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 20 - 20
  • [23] Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients
    Foppa, Caterina
    Maroli, Annalisa
    Luberto, Antonio
    La Raja, Carlotta
    Spaggiari, Paola
    Bonifacio, Cristiana
    De Zanet, Stefano
    Montorsi, Marco
    Piscuoglio, Salvatore
    Terracciano, Luigi Maria
    Santoro, Armando
    Spinelli, Antonino
    CANCERS, 2023, 15 (14)
  • [24] NOT EVERYONE BENEFITS FROM NEOADJUVANT THERAPY FOR RECTAL CANCER.
    Chang, C.
    Bliggenstorfer, J. T.
    Liu, J.
    Bingmer, K.
    Ginesi, M. C.
    Stein, S. L.
    Steinhagen, E.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [25] Genotype-guided neoadjuvant therapy for rectal cancer.
    McLeod, HL
    Tan, B
    Malyapa, R
    Abbey, E
    Picus, J
    Myerson, R
    Zehnbauer, B
    Mutch, M
    Dietz, D
    Fleshman, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 197S - 197S
  • [26] Treatment patterns in metastatic early-onset rectal cancer
    Thompson, Nasya
    Waddell, Oliver
    Mccombie, Andrew
    Frizelle, Francis
    Glyn, Ms Tamara
    ANZ JOURNAL OF SURGERY, 2024,
  • [27] Comment on: "Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial"
    Qiao, Letian
    Liu, Yuan
    Yang, Qiumin
    BRITISH JOURNAL OF CANCER, 2024, 130 (09) : 1432 - 1433
  • [28] Tumor characteristics and treatment in early-onset colorectal cancer.
    Burnett-Hartman, Andrea
    Powers, John D.
    Chubak, Jessica
    Corley, Douglas
    Ghai, Nirupa R.
    McMullen, Carmit K.
    Pawloski, Pamala A.
    Feiglelson, Heather S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [29] Menstrual risk factors and early-onset breast cancer.
    Butler, LM
    Potischman, NA
    Brinton, LA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (11) : S90 - S90
  • [30] PATHOLOGICAL COMPLETE RESPONSE IN PATIENTS WITH YPT0 PRIMARY TUMOR AFTER NEOADJUVANT THERAPY FOR RECTAL CANCER.
    Qureshi, S.
    Reickert, C.
    Asai, M.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)